Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2787_Библиотеки_им_академика_М_И_Перельмана
.pdf
116 Index
https://t.me/medicina_free
transplantation, 105
trauma, 4
Pancreatectomy, 4
Pancreatitis, 4
Panretinal laser photocoagulation,
68
Panretinal photocoagulation, 67
Papaverine, 87
Patient education, 33–34
PCSK9 inhibitors, 99
PDE5 inhibitors, 87
Percutaneous coronary
intervention (PCI), 79
Perioperative management, 53–54
Peripheral vascular disease, 71, 77,
78, 79, 80
Permanent prenatal diabetes
mellitus (PNDM), 16
Peroxisome proliferator-activated
receptors (PPARγ)
agonists, 44
Phaeochromocytoma, 4
Phentolamine, 87
Phosphate, 60
Phosphodiesterase inhibitors, 87
Phosphodiesterase type 5 (PDE
5), 87
Photocoagulation, 67
Pioglitazone, 44
Pitavastatin, 98
Plasma glucose, 60
Platelet-derived growth factor, 86
Polymorphisms, 8
Postoperative infection, 54
Postprandial lipids, 98
Potassium, 61
Potassium loss, 59
Prader–Willi syndrome, 17, 18
Prandial glucose regulators, 44
Pravastatin, 98
Prediabetes, 3, 6
Pregabalin, 77
Pregnancy, 5, 100–102, see also
Gestational diabetes
mellitus (GDM)
Caesarean section rates, 101
insulin regimes, 101
perinatal problems, 100
Preproliferative retinopathy, 65
Prevention trials, pharmacological
ACTNOW (pioglitazone), 26
DREAM (Ramipril and
Rosiglitazone), 26
NAVIGATOR (Nateglinide and
Valsartan), 26
ORIGIN (Insulin Glargine),
26
Priapism, 87
Problem Areas in Diabetes (PAID)
Scale, 103
Proinsulin, 30
Proliferative diabetic retinopathy,
67
Proteinuria, 69–71
Pseudomonas, 80
Pump-treated patients, 60
Q
Quality of life issues, 104
R
Rabson–Mendenhall syndrome, 22
Ramipril, 80
Random plasma glucose
concentration, 3
Ranibizumab, 67
Rapilose, 57
Reaven’s syndrome, see Insulin
resistance syndrome
Regulatory T cells (Tregs), 25
Renal
artery stenosis, 71, 80
failure, 71–72
glomerulopathy, 70, 71
transplantation, 73
Renal-angiotensin-aldosterone
system (RAAS), 71
Retinopathy, 52, 63–69, 71, 103
background, 63
end-stage, 67
exudative, 65
peripheral proliferative, 66
serious, 69
severe, 67
Revita Duodenal Mucosal
resurfacing technique,
107–109
Rosiglitazone, 44
Rosuvastatin, 98
Rubella, congenital, 8
S
Scandinavian Simvastatin Survival
Study (4S Trial), 98
Semaglutide, 45
Serious diabetic retinopathy, 65
SGLT (sodium/glucose
cotransporter) inhibitors,
61
SGLT-2 inhibitors, 46, 54
Shoulder dystocia, 100
Sildenal, 87
Simvastatin, 98
Sitagliptin, 44
Skin abnormalities in diabetic
patients, 91
Skin disorders
acanthosis nigricans, 90, 91
balanitis, 95
bullae, 92
candidiasis, 95
dermopathy, 92
eruptive xanthomata, 91, 92, 93
granuloma annulare, 93
migratory necrolytic erythema, 93
necrobiosis lipoidica
diabeticorum, 91–92
severe bacterial infection, 95
uncommon, 91
vitiligo, 91, 92
Sodium-glucose co-transporter-2
(SGLT2) inhibitors, 72
Sodium valproate, 77
Somatostatin, 11
Spina bida, 100
Staphylococcus aureus,
Statin therapy, 98–99
lipid-lowering combination
therapy
statin/ezetimibe, 99
statin/brate, 99
Steatohepatitis, 90
Stress response, 53
Study to Prevent Non-Insulin
Dependent Diabetes
Mellitus (STOP-NIDDM)
Trial, multinational, 26
Sulphonylureas, 42–43, 54, 56, 57
Surgery, 53–55
perioperative management, 53–54
postoperative infection, 54
80
Index 117
https://t.me/medicina_free
Swedish Obesity Study, 107
Syndrome X, see Insulin resistance
syndrome
Systolic blood pressure (SBP), 80
T
Tachycardia, 76
Tad a la l, 87
T-cell depletion, 106
T1DM TrialNet Study Group trial,
25
Teplizumab, 107
T-helper cells, 9
iazide, 4
iazolidinediones, 44
iazolineidiones (glitazones), 44
Tirzepatide, 45
T lymphocytes, 8–9
Total-contact cast (TCC), 84
Transient neonatal diabetes
mellitus (TNDM), 16
Transplantation
islet cell, 105, 106
renal, 73
whole-pancreas, 105
Treatment Options for Type 2
Diabetes in Adolescents
and Youth (TODAY), 52
Triamcinolone, 68
Tricyclic antidepressants, 77
Triglycerides, 98
Trimethoprim-sulphamethoxazole,
85
Troglitazone, 44
Troglitazone in Prevention of
Diabetes (TRIPOD)
study, 26
Truncal radiculopathy, 75
Tumor necrosis factor (TNF)-α, 10
Turner’s syndrome, 4, 17, 21
Type 1 diabetes, 2
classication, 4
dietary advice, 33
environmental factors, 8–10
epidemiology, 6
genetic factors, 7–8
incidence, 3
insulin requirements in children
with, 51
male excess, 6
pathogenesis, 7–10
pre-insulin treatment, 2
prevention, 24–25, 107
towards a cure for, 105–107
treatment
dietar y, 33
dietary management and
patient education, 33–34
glucose monitoring, 34–35
insulin, 47
insulin preparations,
development of, 30–33
insulin pump treatment
and closed-loop insulin
delivery, 35–37
psychological aspects, 37–38
Type 2 diabetes, 10
childhood, 4, 52
classication, 4
dietary treatment, 42
drug treatment,
epidemiology, 6
histological abnormality in,
15
incidence, 1
insulin resistance in, 14–16
insulin secretion in, 14
lipoprotein abnormalities in,
98
pathogenesis, 14
prevention, 25–26
reversal of, 27
surgical and endoscopic
interventions, 107–110
treatment
α-glucosidase inhibitors, 44
biguanides (metformin), 43
cardiovascular outcome
studies, 47
drugs, 44
HbA
1c
incretin-based treatments,
44–45
insulin, 41, 47
meglitinides, 44
SGLT-2 inhibitors, 46
sulphonylureas, 42–43
thiazolineidiones
(glitazones), 44
treatment strategies and
guidelines, 47–48
42, 43
targets, 33
U
UK National Pregnancy in Diabetes
Audit, 100
United Kingdom Prospective
Diabetes Study (UKPDS),
41, 43, 63
Blood Pressure Control Study,
80
HbA
target, 33
1c
V
Vanc omyc i n, 85
Vardenal, 87
Vascular endothelial growth factor
(VEGF) inhibitors, 67
Vertex, 106, 107
Very-low-density lipoprotein
(VLDL), 27, 98
ViaCell, 106
Vibration controlled transient
elastography (VCTE), 90
Viral associations
adenovirus, 17
Coxsackie B virus, 8, 9, 17
cytomegalovirus, 8, 17
Epstein–Barr virus, 8
Visual impairment, 103
Vitiligo, 91, 92
Vitreoretinal surgery, 67
Vitreous haemorrhage, 69
W
Weight-bearing forces, reduction
of, 85
Weight loss, 25, 26, 42
Whole-pancreas transplantation,
105
Wolfram’s syndrome, 17
World Health Organization (WHO)
diagnostic criteria, 3
Z
Zinc transporter, 9
Соседние файлы в папке Библиотека им академика М.И. Перельмана